<?xml version="1.0" encoding="UTF-8"?>
<SMARTSAlert>
  <AlertID>ITA-2024-003289</AlertID>
  <AlertType>Pre-Announcement Trading</AlertType>
  <RuleViolated>MAR-03-002</RuleViolated>
  <GeneratedTimestamp>2024-05-20T09:45:00Z</GeneratedTimestamp>

  <Trader>
    <TraderID>T003</TraderID>
    <Name>Michael Chen</Name>
    <Department>Research</Department>
  </Trader>

  <SuspiciousActivity>
    <Symbol>PHARMAX</Symbol>
    <TradeDate>2024-05-18</TradeDate>
    <Side>BUY</Side>
    <Quantity>25000</Quantity>
    <Price>42.75</Price>
    <TotalValue>1068750</TotalValue>
  </SuspiciousActivity>

  <AnomalyIndicators>
    <AnomalyScore>71</AnomalyScore>
    <ConfidenceLevel>MEDIUM</ConfidenceLevel>
    <TemporalProximity>72 hours before FDA approval announcement</TemporalProximity>
    <EstimatedProfit>287500</EstimatedProfit>
  </AnomalyIndicators>

  <RelatedEvent>
    <EventType>FDA Approval</EventType>
    <EventDate>2024-05-21</EventDate>
    <EventDescription>PHARMAX receives FDA approval for new cancer treatment drug</EventDescription>
  </RelatedEvent>
</SMARTSAlert>
